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1. Introduction 
Water scarcity forces people to rely on unsafe sources of drinking water. The use of poor water quality can increase the 
risk of waterborne diseases (e.g. cholera, typhoid fever, etc.). Every year almost 2 million child deaths are counted 
related to unclean water and poor sanitation (UNDP, 2006). 
Although Millenium Development Goal (MDG) number 7 aims to halve by 2015 the proportion of people without 
sustainable access to safe drinking water and basic sanitation, the situation is getting worse. Water scarcity is an 
increasing problem, as needs for water rise along with population growth, urbanization and higher industrial and 
domestic water demand. On national and local scales, there is a need for appropriately funded infrastructure and robust 
governance mechanisms in order to protect water resources and ensure a sustainable development and distribution of 
water-derived benefits. Initiatives are emerging worldwide to attain this matter. For that reason, wastewater treatment, 
reuse and reclamation represent key practices in that approach (UNESCO, 2012). 
More than one-third of the planet’s accessible renewable freshwater is used for agricultural, industrial and municipal 
purposes. Most of the activities eventually lead to the contamination of freshwater systems worldwide with thousands of 
industrial and natural chemical compounds. Some 2 million tons of waste, derived from all industrial and human 
activities (e.g. synthetic compounds used in industrial and consumer products; diffuse agricultural pollution from the 
application of fertilizers and pesticides; oil and gasoline components through accidental spills, etc.) are released into 
receiving waters everyday with incomplete or no treatment at all (Fig. 1.1) (UNESCO, 2003; Schwarzenbach et al., 
2006). 
 
Figure 1.1. Ratio of treated to untreated wastewater discharged into water bodies. (Source: adaptation of UNESCO, 2012). 
During the last decade, the occurrence of organic micropollutants in the environment has attracted great interest since a 
generalized concern arise about the possible undesirable effects of many of these pollutants in the environment and to 
living organisms (Cunningham et al., 2006; Kümmerer et al., 2009). The trace pollutants referred to as ‘emerging 
organic contaminants’ (EOCs) mainly comprise a group of man-made compounds such as pharmaceutical and personal 
care products (PPCPs), pesticides, plasticizers and antiseptics that are continuously discharged into the environment as a 
result of consumer activities, waste disposal, accidental releases and purposeful introduction (Daughton, 2004a). 
One of the main sources of EOCs into the environment is the discharge of effluents from wastewater treatment plants 
(WWTPs), where their removal is usually incomplete (Heberer, 2002). Although a whole array of advanced treatment 
technologies have lately appeared aiming at the elimination of EOCs, such as ozonation, chemical advanced oxidation or 
UV radiation (Kim et al., 2009; Liu et al., 2009; Rosal et al., 2010) and have shown to enhance their elimination, the cost 
of these treatments is oftentimes too expensive and not justified under the current concept and standards of sanitation and  3 
wastewater treatment. Moreover, they could lead to the generation of transformation products being in some cases more 
persistent or toxic than the parental compound (Fatta-Kassinos et al., 2011). 
To this regard, decentralized, extensive low-cost treatment technologies, such as constructed wetlands, emerge as a great 
alternative for wastewater treatment and reuse, which require almost no maintenance and energy consumption. 
Constructed wetlands (CWs) are natural wastewater treatment systems that emphasize the processes happening in natural 
wetlands in order to improve their treatment capacity (Kadlec and Wallace, 2009). They constitute an alternative cost-
effective technology to conventional WWTPs, in particular in the context of small communities with less than 2000 
people equivalent (PE) (Puigagut et al., 2007). Apart from the removal of conventional wastewater pollutants (e.g. 
biochemical oxygen demand, total suspended solids, nitrogen, phosphorus, etc.) and heavy metals, CWs have proven to 
have a great potential for the removal of EOCs. The existing literature includes mostly studies on the occurrence and 
behavior of pharmaceuticals at horizontal flow (HF) wetlands at micro and meso-scale (Matamoros et al., 2008a; Ávila 
et al., 2010; Hijosa et al., 2010b; Dordio et al., 2010; Hijosa et al., 2011b; Zhang et al., 2011; Reyes-Contreras et al., 
2012; Zhang et al., 2012b; Ávila et al., 2013a), as well as pilot-scale (Matamoros and Bayona, 2006; Matamoros et al., 
2005). Moreover, several studies have been carried out in vertical flow (VF) systems (Matamoros et al., 2007; 
Matamoros et al., 2009a; Song et al., 2009) and others at full-scale tertiary treatment systems, which include the use of a 
free water surface (FWS) wetland (Matamoros et al., 2008b; Llorens et al., 2009; Hijosa et al., 2010a; Matamoros and 
Salvadó, 2012). A couple of other examples comprise the use of a CW after a previous treatment system like a 
conventional WWTP or an anaerobic digester (Reyes-Contreras et al., 2011; Verlicchi et al., 2013), and the use of a 
three-stage hybrid constructed wetland systems based on different wetland types (Ávila et al., 2014a, b). As an example, 
an aerial view of a surface constructed wetlands system, acting as a tertiary treatment unit after a conventional activated-
sludge unit in Spain, which was evaluated by Matamoros et al. (2008b) can be observed in Figure 1.2.  
 
Figure 1.2. Aerial view of the activated sludge WWTP and tertiary treatment constructed wetland system at the Natural Park of 
Aiguamolls de l’Empordà, Girona, Spain (photo: Consorci Costa Brava). 
With the purpose of providing further insight about the occurrence and possible undesirable effects of pharmaceuticals 
and personal care products in the environment, as well as the technologies which could avoid their release into the 
aquatic environment, in the current chapter we will describe the current knowledge on their source, fate and removal in 
conventional wastewater treatment plants and tertiary treatment units.   4 
Finally this chapter reviews the efficiency of constructed wetlands at removing pharmaceuticals and personal care 
products from domestic wastewater.  
1.1. Emerging organic contaminants 
Emerging organic contaminants (EOCs) are, in most cases, unregulated contaminants whose emissions have emerged as 
an environmental problem. They comprise a diverse collection of thousands of chemical substances, such as 
pharmaceuticals, personal care products (PCPs), pesticides, hormones, surfactants, flame-retardants, plasticizers, 
industrial additives and agents, as well as their transformation products (Farré et al., 2008). The steady increase in the 
manufacture and consumption of this type of compounds (Campbell, 2007), together with the development of new 
analytical techniques that have allowed their detection (González et al., 2007, Farré et al., 2012), and attracted the 
attention and concern of the scientific community around a decade ago (Halling-Sorensen et al., 1998). Since then, a 
number of authors have done extensive research about the occurrence, fate and ecotoxicological effects of these 
pollutants in the environment (Kolpin et al., 2002; Cunningham et al., 2006; Barceló and Petrović, 2007; Brooks et al., 
2012). 
Europe stands as a pioneer in this field and many programs/projects are carried out, which investigate the occurrence, 
fate and ecotoxicology of these pollutants in all the different compartments of the aquatic environment, as well as 
potential solutions concerning the elimination of these in wastewater. Some examples of finalized projects are: 
- POSEIDON (2001-2004): Assessment of Technologies for the Removal of Pharmaceuticals and Personal Care 
Products in Sewage and Drinking Water Facilities to Improve Indirect Potable Water Reuse 
- P-THREE (2002-2005): Removal of Persistent Polar Pollutants through Improved Treatment of Wastewater 
Effluents 
- EMCO (2004-2007): Reduction of Environmental Risks, Posed by Emerging Contaminants, through Advanced 
Treatment of Municipal and Industrial Wastes 
- ERAPharm (2004-2007): Environmental Risk Assessment of Pharmaceuticals 
- KNAPPE (2007-2008): Knowledge and Need Assessment on Pharmaceutical Products in Environmental Waters  
- PILLS (2009-2012): Pharmaceutical Input and Elimination from Local Sources  
In September 2005 the NORMAN network (Network of reference laboratories for monitoring of emerging 
environmental pollutants) was created with the financial support of the European Commission, with the purpose of being 
a self-sustaining network of reference laboratories, research centers and related organizations around Europe for the 
monitoring and biomonitoring of EOCs. The aim is to enhance the exchange of information, to harmonize methodologies 
and to stimulate coordinated, interdisciplinary projects on problem-oriented research to address identified needs. 
Likewise, the Environmental Protection Agency (EPA, USA) has also made great efforts to raise attention about the 
potential problems derived from the ubiquity of pharmaceuticals in the environment, not only asking scientist to increase 
the research on the field, but also calling the attention of authorities, health care providers, pharmaceutical companies 
and patients (Daughton and Ternes, 1999; Daughton, 2004b). The ultimate goal is to develop mitigation practices to 
tackle this environmental problem and to avoid the risk associated with these pollutants (Barceló, 2003). 
However, though major strides have been made in the last years in increasing knowledge about the matter, one of the 
main conclusions at this point is that knowledge about emerging contaminants’ fate and impact in the environment and 
living organisms is, however, fragmentary, and often dealing with only a part of the problematic, and therefore much 
remains to be understood (KNAPPE, 2008). 
Out of the rich array of EOCs, the ones receiving the greatest attention up to date are the following: antibiotics, due to 
the increase in antibiotic resistance genes in aquatic microbiota and potentially human pathogens (Díaz-Cruz et al., 2003; 
Knapp et al., 2010; Patra et al., 2012; Rodríguez-Rojas et al., 2013); then, X-ray contrast media, which have shown high 
persistence in the environment; cytostatic drugs, which, being majorly used in the chemotherapy of oncological patients,  5 
are designed to prevent the growth and proliferation of cells, and thus are considered highly hazardous compounds due 
to their genotoxic properties (Zhang et al., 2013); and finally endocrine disrupting compounds (EDCs) such as estrogens, 
PCBs and organochlorine pesticides (e.g. DDT), among others, which have been found to induce disruption of the 
reproductive system, female and male reproductive health in humans and wildlife, sex ratio (in wild fish and mollusks), 
neurodevelopment in children and wildlife, as well as to cause hormone-related cancers, bone disorders, metabolic 
disorders, and even immune function, diseases and disorders in humans and wildlife (Bergman et al., 2013). 
Daughton (2004b) conducted a great discussion about the universe of chemicals that occur in the environment, both 
known (regulated or not) and unknown, so as to put efforts in widening the understanding of the exposure and risk of 
chemicals in ecosystems and human health. A large portion of the chemicals occurring in analyzed water samples are not 
(or cannot be) identified, due to limitations in the repertoire of available analysis tools. Everyday, and for decades now, a 
whole array of new drugs are released into the environment with mechanisms of action never before encountered by 
biological systems, and only a very small percentage of commercially used contaminants are being investigated. 
Definitively, industrial and technological advances in respect to the production of chemicals poses substantial challenges 
to the evolution and design of regulatory practices. 
The limited information on the occurrence, fate and effects of EOCs makes it difficult for authorities to regulate their 
disposal and limit their concentrations. Some groups of compounds have received regulation, such as pesticides and 
other priority pollutants (EC, 1976). Moreover, the European Commission is working on the preparation of a candidate 
list of 553 endocrine disrupting compounds (EDCs) so as to prioritize further detailed review of these. In this list, the 
industrial chemical bisphenol A (monomer of hard plastics and eposy resins) and the estrogenic steroid hormone 17α-
ethinylestradiol are included, among others, together with many new pesticides and other industrial chemicals (EC, 
2000b). This list is subjected to changes in response to developments in scientific knowledge or changes in patterns of 
chemical usage. On the other hand, in the USA the EPA holds a list of compounds called the Contaminant Candidate 
List (CCL), which comprises a list of contaminants that although are not subject to any drinking water regulation, are 
being monitored with the aim of possibly being included in future regulations. The last one includes several EDCs, and 
some flame-retardants (CCL3, 2008). 
However, there are no laws, acts or regulations of any kind, which include guidelines for EOCs concentrations in 
WWTPs, drinking water facilities or the environment. The lack of regulations allows unlimited and widespread 
discharge of EOCs in the environment, which have unknown consequences for the environment and public health. 
Efforts should be harmonized and integrated between the different actors involved in EOCs’ lifecycle, as well as 
researchers and public authorities, so as to obtain more productive outcomes and understanding of the problematic and to 
take action to limit their presence in the environment (Schwarzenbach et al., 2006; KNAPPE, 2008; Daughton, 2009). 
1.1.1. Pharmaceuticals and personal care products 
There is a large number of EOCs that are continuously released to the environment due to their wide use in society. A 
subclass underneath this class is pharmaceuticals and personal care products (PPCPs), which in turn comprise an 
extraordinarily diverse group of chemicals used in veterinary medicine, agricultural practice, human health and cosmetic 
care. 
PPCPs include prescription and non-prescription medications, nutritional supplements, diagnostic agents, as well as 
other consumer products such as disinfectants, fragrances, sunscreen and cosmetics. Even though most of them are polar, 
have a short half-lifetime in water, and are found in trace concentrations, they are considered pseudo-persistent 
pollutants (Barceló and Petrović, 2007). This is because their universal, frequent usage by multitude of individual and 
animals causes a continuous discharge into the environment often times sourcing from either non-treated or insufficient 
wastewater treatment. 
The molecular structures of PPCPs are typically large and complex, and differ a lot among substances, containing 
functional groups such as hydroxyl, carboxyl, ketone and amine. It is important to note that the classification of 
pharmaceuticals by their active substances within subgroups of pharmaceuticals does not imply that they follow a certain 
chemical behavior. Small changes in the chemical structure may have significant effects on solubility and polarity, and 
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other properties, which will in turn determine their environmental distribution in air, water, sediments, soils and animals 
(Kümmerer, 2009). 
One of the physico-chemical properties of organic compounds most applied in the field of environmental chemistry is 
the n-octanol water partition coefficient (Kow), which is defined as the ratio of the compound’s concentration in a known 
volume of n-octanol to its concentration in a known volume of water at equilibrium and at constant temperature. Kow 
values are constant for a given compound and reflect the lipophilicity of a compound. Hence, the higher the Kow of a 
chemical, the higher its lipophilicity. Kow values are generally directly proportional to molecular weight. 
Kow values can be measured in the laboratory with shake-flask systems, or can be estimated by models. Kow values have 
been measured for a wide variety of chemicals and range from about 0.001 to over 10,000,000. Since the range of Kow 
values encompass ten orders of magnitude, log Kow values are used instead, and range -3 to 7. A substance is usually 
considered lipophilic at log Kow values ranging 3-4 to 6.5 (Kow >100) (Connell, 2005). 
However, Kow assays are done adjusting the pH of the aqueous phase so that the predominant form of the compound is 
unionized. In this way, although some substances could be expected to be fairly lipophilic when having log Kow values 
ranging 3-4, the occurrence of carboxylic groups or other polar groups in their structure are prone to be ionized and thus, 
increasing their hydrophilicity. Since many pharmaceuticals are ionizable at environmental pH conditions, log Kow might 
not always be an appropriate predictor of the hydrophobicity of a compound. In particular, most non-steroidal anti-
inflammatory drugs (NSAIDs) are ionized at environmental pH, and behave as highly polar compounds. Hence, for 
weak acids the hydrophobicity also depends on its pKa and the occurring pH of the media where they are contained (Eq. 
1). 
The ionization constant (Ka) is a measure of (weak) acid strength as expressed by the concentration of ionized molecules 
divided by the concentration of unionized molecules. In this way, the lower the pKa, the higher the Ka and the stronger 
the acid.  
where, 
log [A-]/[AH] = pH - pKa                           (Equation 1) 
Hence, for a given pKa of a compound, the higher the pH, the higher the ionization of the compound. 
To this regard, the octanol-water distribution coefficient (Dow), which is defined as the ratio of the sum of all forms of 
the compound (ionized + unionized) in each of the two phases, constitutes a better descriptor for ionizable compounds. 
In this case the pH of the aqueous phase is buffered to a specific value such that the pH is not significantly perturbed by 
the introduction of the compound. The log Dow is pH dependent, and hence one must specify the pH at which the 
parameter was measured. For unionizable compounds, log Kow = log Dow at any pH, however for many pharmaceuticals 
such as NSAIDs (e.g. ibuprofen, diclofenac), the molecule occurs mainly in its ionized form and thus holds a hydrophilic 
behavior at environmental pHs (log Dow = 1.1 for both substances at pH =8). 
In the case of personal care products (PCPs), fragrances are generally semi-volatile organic compounds, fairly 
hydrophobic substances, which have been for many centuries used for multiple purposes (e.g. perfumes, deodorants, 
washing and cleaning agents, cosmetics). Typical concentrations of fragrances range from 0.3% in face creams to as 
much as 20% in perfume extracts (Cadby et al., 2002). Most of the fragrances used nowadays are synthesized by 
industry, and nitro musks and polycyclic musks are the two main categories. The latter are the major musks used today, 
accounting for almost two-thirds of worldwide production, with an estimated worldwide production volume of 6000 t 
year-1 (Rimkus, 1999). Tonalide (AHTN) is one of the most widely used polycyclic musks around the world and is used 
in cosmetics and detergents. It is designed to be very lipophilic in order to sorb to organic materials such as the skin, and 
in consequence is poorly soluble in water, as indicated by its high octanol-water coefficient (log Kow = 5.9). Moreover, 
oxybenzone (OXY) is an organic ultraviolet filter used in sunscreen and other cosmetics. Another commonly found PCP 
is triclosan (TCS), an antibacterial and antifungal agent present in soaps, deodorants, toothpastes, shaving creams, and in 
a number of consumer products (MedlinePlus, 2010). PCPs differ from pharmaceuticals in that large amounts can be 
directly introduced in the environment, by direct release into recreational waters or volatilized into the air (e.g. musks). 
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1.1.2 Transformation products 
The compounds resulting from the structural change of pharmaceuticals within the human body are called metabolites. 
As with metabolism, when a substance is introduced to the environment or a treatment plant, it can undergo different 
structural changes by a variety of biotic (e.g. biodegradation, biotransformation) and non-biotic processes (e.g. 
phototransformation, hydrolysis) resulting in partial or complete transformation of the original compound. This results in 
changes in their physico-chemical properties, which in turn affects their behavior and toxicity. Although the 
transformation of parent compounds could be expected to reduce toxicity, in some cases transformation products could 
have higher persistence and/or more harmful effects than the parent substance. This has particularly been found during 
natural and technical photolytic processes and advanced oxidation processes (AOPs) (Kümmerer, 2009; Fatta-Kassinos 
et al., 2011; Benítez et al., 2013). 
Little is known about the degradation pathways and products of most PPCPs in the environment, and less is known about 
their intermediates of degradation, which just started to be explored (Miao and Metcalfe, 2003; Farré et al., 2008). 
Gómez et al. (2012) just recently found transformation products of various PPCPs at the Henares River basin (central 
Spain) at concentrations much higher than those of their parent compounds. Various transformation products of 
ibuprofen and other pharmaceuticals were identified by Quintana et al. (2005) in municipal wastewater treated by a 
membrane bioreactor. 
These findings highlight the importance of including degradation products in monitoring and research programs so as to 
have a better understanding of the behavior and potential toxicology of PPCPs in the environment. However, it is 
important to have in mind that given the universe of chemicals that are everyday released into the environment and, the 
difficulty and expense involved in their analysis, it would be impossible (if not infinite) to take them all into 
consideration for research programs or rutinary monitoring. Instead, well-balanced efforts must be put based on 
predicted risks associated to each specific contaminant in order to find a compromise solution. 
1.2. Sources and fate of pharmaceuticals and personal care products in the environment 
Contaminants enter the environment through multitude of sources, whose components are depicted in Fig. 1.3. 
 
 
Figure 1.3. Sources and fate of contaminants in the (partially) closed water cycle with indirect potable re-use (from Petrović et al., 
2003).  8 
Consumption of PPCPs is high worldwide. As an example of human consumption, it is worth noting how the 
consumption of non-steroidal anti-inflammatory drugs (NSAIDs) in Spain raised from 26.30 DHD (defined daily 
doses/1000 inhabitants·day) to 45.81 DHD from 1992 to 2006 (AEMPS, 2006). Out of the NSAIDs, one of the 
compounds attaining the greatest increase was ibuprofen, whose consumption increased from 0.29 DHD in 1992 up to 
21.30 in 2006. The NSAID DCF (commonly known as voltaren) however showed rather stable values of consumption 
overtime, averaging 7 DHD. According with IMS Health data 942 tons of the anticonvulsant carbamazepine and 877 
tons of DCF were sold in 2007 in 76 major countries, which are believed to account for 96% of the global 
pharmaceutical market. Antibiotic consumption did not fluctuate a lot during the last decade in Spain as it is shown in 
the report of the AEMPS (2009). Values ranged 0.1 DHD for most studied quinolones up to a maximum value of 6.6 
DHD found for the peniciline amoxicilin. As it can be seen in the report by the OECD, most countries in the world have 
experimented a significant increase in consumption of pharmaceuticals in the last decade (OECD, 2013). To this regard, 
Daughton and Ruhoy (2013) have called to note the importance of prescribing the “lowest effective dose” of 
pharmaceuticals on patients as a strategy to diminish PPCP concentrations in the environment and eventually avoid 
potential adverse environmental impacts. 
Once pharmaceuticals are ingested and a fraction metabolized, they are excreted and reach the urban sewer network up 
to the wastewater treatment plants. The current treatment processes applied for municipal wastewater treatment often fail 
to completely remove PPCPs, which leads to their subsequent release in the terrestrial and aquatic ecosystems through 
disposal and reuse applications. 
On the other hand, the second major source of PPCPs in the environment after sewage effluent discharge is terrestrial 
run-off derived from the agrifood (and especially meat) industry. To have an idea of the levels of consumption of 
antibiotics on livestock farms, while human antibiotic use in the USA is maintained below 8 billion pounds per year, 
livestock farms have been increasing their use, constituting to date nearly four-fifths of the total amount of antibiotics 
used in the USA (FDA, 2011). 
A significant source of concern for PPCPs in groundwater is the leaching from municipal landfills. Improper disposal of 
unused or expired drugs (either through the toilet or landfill) constitute another source of these contaminants in the 
environment. Depending on the physico-chemical characteristics of the organic contaminant (and their transformation 
products) and the characteristics of the soil, PPCPs can either reach groundwater and pollute aquifers or remain retained 
within the soil and eventually accumulate, thus affecting the ecosystem and human beings through the food-web. As a 
matter of fact, PPCPs have been detected at trace concentrations in the freshwater environment for decades (Halling-
Sorensen et al., 1998; Kolpin et al., 2002; Loos et al., 2009, 2010; Jurado et al., 2012). As a particular example, Kim et 
al. (2007) documented the frequent detection of many pharmaceuticals, hormones, antibiotics, as well as flame-
retardants in surface waters in South Korea. Various endocrine disrupting compounds (EDCs), as well as associated 
toxicological effects over caged male fathead minnows, were found in 90% of sediment and water samples of 11 studied 
lakes across Minnesota, USA (Writer et al., 2010). Stackelberg et al. (2004) found pharmaceuticals compounds and other 
organic wastewater contaminants in a conventional drinking-water-treatment plant before and after treatment. 
Pharmaceuticals were also found at the ng L-1 level in the tap water of Berlin (Heberer, 2002). The authors attribute this 
phenomenon to be characteristic of conurbations like Berlin, with high municipal wastewater discharges and low surface 
water flows, when groundwater recharge is used in drinking water production. 
Some other scattered examples, which show the ubiquity of the occurrence of PPCPs in various compartments of the 
aquatic environment around the world, are displayed in Table 1.1. 
Table 1.1. Minimum, maximum and average concentrations (in ng L-1) of various PPCPs in natural water bodies around the globe. 
 Min Max Avg Sample source Reference 
Diclofenac 10 50 29 River Elbe and at the mouth of its 
tributaries (Germany) 
Wiegel et al. (2004) 
Ibuprofen <20 70 35 
Acetaminophen <5 65 16 
Bisphenol A 16 100 40 
Ibuprofen 11 38 28 Han, Nakdong and Youngsan rivers (South Kim et al. (2007)  9 
Acetaminophen 4 73 33 Korea) 
Diclofenac 1 6.8 3.0 
Oxybenzone 1 3 2 
Acetaminophen <LOD 712 - Ebro River basin (Spain) López-Serna et al. (2012) 
Triclosan <LOD 8 n.a. Surface waters of Greenwich Bay (USA) Katz et al. (2013) 
Acetaminophen 2 17 5 Near-shore habitats of Lake Michigan -
river discharges into the lake from 
predominantly urban watersheds (USA) 
Ferguson et al. (2013) 
Ibuprofen 2 84 8 
Carbamazepine 2 118 40 Aquifers at the delta area of the Llobregat 
River (NE Spain) 
Teijón et al. (2010) 
Ibuprofen <LOD 185 185 
Diclofenac 35 477 256 
Acetaminophen - 1890 180 Groundwater used for drinking-water 
supply in California (USA)  
Fram and Belitz (2011) 
Diclofenac <LOD 1.2 0.2 Urban groundwater in the district of Poble 
Sec, Barcelona (Spain) 
López-Serna et al. (2013) 
Ibuprofen <LOD 2 0.2 
Acetaminophen <LOD <LOD <LOD 
Erythromycin <LOD <LOD <LOD 
Enrofloxacin 12 264 75 
Ibuprofen <LOD 200 - Berlin groundwater wells (Germany) Heberer (2002) 
Diclofenac <LOD 380 - 
Clofibric acid <LOD 7300 - 
Concentrations of PPCPs in surface waters (primarily due to their incomplete elimination in WWTPs) as well as 
groundwater (due to filtration through the soil) are in the range of ng L-1 to µg L-1. The different pathways that PPCPs 
can undertake from resource up to drinking water level are explained in detail in the study by Halling-Sørensen et al. 
(1998). In general, the polar nature and low volatility of PPCPs prevents their escape from the aquatic realm, being 
primarily distributed through aqueous transport and food chain dispersal (Daughton and Ternes, 1999). Although the 
half-life in aquatic ecosystem for most PPCPs is relatively low (Yamamoto et al., 2009), some substances are fairly 
recalcitrant and may accumulate in soil, reaching concentrations of g kg-1. As an example, clofibric acid (a compound 
used for reducing cholesterol levels in blood) has been found to have a half-life of 21 years in soil (Hernando et al., 
2006). In relation to this, the application of sewage sludge could eventually contribute to soil, surface and groundwater 
contamination, either by accumulation of these contaminants in soil in the long term, or by possible leaching and 
migration of contaminants through the soil zone (Chen et al., 2011; Stuart et al., 2012). Another major pathway of 
groundwater contamination is due to groundwater-surface water interaction through infiltration from losing reaches of 
rivers, especially near industrial premises and sewage works (Stuart et al., 2012). The contamination of the groundwater 
could pose serious challenges to safety regarding drinking water supply. A recent study by the GAO (2011) showed that 
most drinking water samples grabbed in USA were contaminated by pharmaceuticals, mostly estrogen-based hormones 
and antibiotics. 
Moreover, there is a clear need to include irrigation as an additional exposure route for PPCPs in terrestrial ecosystems, 
so as to assess the potential risks derived. Driven by the imposing water scarcity, irrigation through water reclamation is 
being widely implemented in Europe for multiple purposes, mainly agriculture, due to the advantages related to nutrient 
recovery, socio-economic implications. The practice of wastewater reuse without proper management poses potential 
risks to human health and the environment due to the potential occurrence of pathogens and chemical pollutants (Muñoz 
et al., 2009; Fatta-Kasinos et al., 2011). 
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1.3. Toxicity and evaluation of risks associated to pharmaceuticals and personal care products 
The ubiquity of PPCPs in the environment has created a great concern among scientists due to the possible toxicological 
effects that these substances may pose on ecosystems and public health. In the last years numerous studies are evaluating 
the possible toxicological effects related to the occurrence of PPCPs and other emerging organic contaminants, mainly 
on aquatic organisms (Fent et al., 2006), as well as the management of risk (Enick and Moore, 2007) with the purpose of 
giving support to decision taking by stakeholders and eventually policy-making. 
Although occurring concentrations of PPCPs in the environment are oftentimes very low (ranging ng L-1 to µg L-1) and 
may not seem to pose an appreciable risk to human health, these are continuously released to the environment, 
constituting so-called “pseudo-persistent” contaminants. In many cases the possible consequences of their occurrence in 
the environment are not well understood, but in others the effects seems evident and alarming. As an example, the 
reduction of 90% of the population of vultures in India, Pakistan and Nepal since the 1990’s is related to the use of the 
anti-inflammatory drug diclofenac on cattle in these countries, and therefore its use as a veterinary drug was banned in 
2005 in India (Oaks et al., 2004; Balmford, 2013).  
What is more, musk fragrances are found to be ubiquitous, persistent, bioaccumulative pollutants in aquatic organisms 
that are sometimes highly toxic (Daughton and Ternes, 1999; Luckenbach et al., 2004; Zhang et al., 2013). Amino musk 
transformation products are toxicologically significant. Polycyclic musks fragrances have been found to accumulate in 
several aquatic organisms, such as fish and mussels, but also in high trophic level aquatic organisms and human breast 
milk (Kannan et al., 2005; Yin et al., 2012). 
It is important to note that pharmaceuticals are designed to be biologically active, by modulating endocrine and immune 
systems and cellular signal transduction, in order to serve their therapeutic purposes. This in consequence will potentially 
affect the physiological and biochemical functions of biological systems and ecosystems. Moreover, some of them are 
estrogen hormones (such as ethynilestradiol), which belong to the category of endocrine disrupting coumpounds (EDCs), 
showing toxicity at ng L-1 levels (Larsson et al., 1999; Ingerslev et al., 2003). However, PPCPs are quite diverse among 
them and therefore they may have very different effects over ecosystems (Halling-Sorensen et al., 1998). Although 
PPCPs have received less scrutiny than pesticides (many are EDCs of concern), these differ from the latter in that the 
disposal of PPCPs is widespread, long-term and in lower doses. Thus aquatic organisms receive a more chronic 
exposure. 
Although little is known about the occurrence and effects of pharmaceuticals in the environment, more data exist for 
antibiotics than for any other therapeutic class. This is a result of their extensive use in human therapy and animal 
husbandry, as well as plant agriculture and aquaculture. It has become clear that the intense use and misuse of antibiotics 
has increased and spread the occurrence of highly resistant pathogenic bacteria. There is real concern about the effects on 
aquatic microbiota and consequent alteration of the structure of the microbial community, as well as on the development 
of resistance in potential human pathogens. Although occurring bacteria in freshwater sources are commonly non 
pathogenic, there could be exchange of genetic material between pathogenic and non-pathogenic bacteria, conferring 
them increased antibiotic resistance (Witte, 1998; Barbosa and Levy, 2000; Cabello, 2006; Schlüter et al., 2007; Kelly et 
al., 2009; Zhang et al., 2009; Middleton and Salierno, 2013). 
Research efforts aiming at elucidating the potential toxicological significance of PPCPs in ecosystems and eventually in 
public health requires documentation of contaminant uptake, modes of action and biological endpoints, as well as 
exposure. Most of the published literature is based on acute effects on aquatic organisms, and in hazard and risk 
assessments. Assessment factors are applied to the acute effects data for extrapolation to chronic (long-term) effects. 
This approach is oftentimes non realistic, given that the ratio between acute and chronic toxicity shows to differ 
depending on the PPCP (Cunningham et al., 2006; Fent et al., 2006). In general, PPCPs do not show high acute toxicity, 
but chronic toxicity and potential subtle effects are marginally known. 
As an example, Cleuvers (2003) found how the non-steroidal antiinflammatory drugs (NSAIDs) ibuprofen (IB) and 
diclofenac (DCF), and the anticonvulsant carbamazepine (CBZ) were toxic for algae, and discuss that although acute 
effects of single substances in the aquatic environment are very unlikely due to the small concentrations, a combination 
effect of several compounds and/or their transformation products can occur. Brausch and Rand (2011) evaluated acute 
and chronic toxicity data available for personal care products, including the antiseptic triclosan (TCS) and the musk 
fragrance tonalide (AHTN). Only TCS and Triclocarban presented any hazard. Moreover, Breitholtz et al. (2012)  11 
assessed the ecotoxicity of various micropollutants on macroalgae and crustaceans in a free water surface wetland in 
Sweden and reported a good quality of the effluent water, comparable to that treated under advanced tertiary treatment 
processes. 
Conversely, Fent et al. (2006) found how a few substances such as DCF, was the compound with the highest acute 
toxicity within the class of NSAIDs, and average concentrations found at the effluent of conventional WWTPs were in 
the range of those being toxic for fish. What is more, Lai et al. (2002), using a food-web model found that natural and 
synthetic estrogens, such as the hormone ethynilestradiol (EE2), could be bioaccumulated in fish in river systems, 
although to a lesser extent than other EDCs such as DDT (Lai et al., 2002). Likewise, AHTN and other fragrances, 
which are made hydrophobic so as to adsorb to tissue might accumulate in aquatic biota (Rimkus, 1999). 
Although acute toxicity in the aquatic systems due to the occurrence of PPCPs is unlikely to occur, there is a lack of 
chronic toxicity data and effects from long-term, low-level environmental exposures should be further addressed, so as to 
have a better understanding of the environmental risk of these compounds. What is more, since pharmaceuticals are not 
present alone in the environment, but as multi-component mixtures, an accurate prediction of the chronic mixture 
toxicity is indispensable for an environmental risk assessment. Significant synergistic toxic effects may occur through 
additive exposures; therefore they should not be handled in isolation. The effects and interaction of a cocktail of 
commonly used pharmaceuticals, including CBZ, IB and the antibiotic sulfamethoxazole were studied using in vitro tests 
on human and zebrafish cells by Pomati et al. (2008), and they found that the mixture of drugs at ng L-1 can inhibit cell 
proliferation on aquatic life. However, the research in this new field of ecotoxicology is just starting and much remains 
to be learned (Kümmerer, 2009; Stuart et al., 2012). 
Another issue of very recent concern is the inhibition of multixenobiotic resistance (MXR) in aquatic organisms, which 
has especially been found in environmental samples from polluted locations. This mechanism is used as a “first line of 
defense” against endogenous and exogenous potentially toxic xenobiotics, which are expelled out of the cell by various 
transmembrane transport proteins. It is still unclear whether the so-called MXR inhibitors or chemosensitizers (Smital 
and Kurelec, 1998) are natural or man-made substances. It is also unknown whether these are constituted by a few 
powerful MXR inhibitors, or if the inhibition is caused by the mere presence of a large number of chemicals in polluted 
water. It is also discussed whether these substances could play key roles in potentiating the effects of other xenobiotics 
(Daughton and Ternes, 1999). Research on this topic has also just been initiated, such as the study of the inhibition of 
MXR by musk fragrances (Luckenbach et al., 2004) and still multiple aspects need to be addressed on this topic (Smital 
et al., 2004). 
Even though ecological effects caused by PPCPs may not be manifest, it does not mean that they do not exist. Potential 
subtle effects of these substances over time may occur (Daughton and Ternes, 1999). In order to have a better 
understanding of mechanisms of action of these contaminants in the environment, the target- or biomolecule-oriented, or 
mode-of-action-based investigation activities are preferred over traditional standard ecotoxicological assays. In general, 
assessing the impact of PPCPs in aquatic systems remains a major challenge, requiring improved analytical and 
modeling tools, the development of methods to classify existing and new chemicals on the basis of their potential to 
harm humans and ecosystems, as well as the development of attenuation technologies and other strategies which 
minimize their introduction into the environment (Schwarzenbach et al., 2006). 
1.4. Occurrence and fate of pharmaceuticals and personal care products in conventional 
wastewater treatment plants 
The occurrence and fate of PPCPs have been extensively assessed in many conventional wastewater treatment 
technologies, such as activated sludge systems, which are oftentimes unable to degrade them, and thus constitute their 
major source point into the environment. The activated sludge process is the most common type of secondary treatment 
used in municipal wastewater treatment plants worldwide. It consists of a two-stage suspended growth biological 
treatment process designed to majorly remove organic matter. The first stage is comprised by an aerated reactor in which 
organic matter is eliminated by a mixed microbial population, while the second stage consists of a settling tank or 
clarifier that separates solids (activated sludge) from water. A portion of the activated sludge is wasted while the rest is 
returned back to the reactor. While hydraulic retention time (HRT) of the water is of about 8 hours, for conventional 
activated sludge, the average solids retention time is 5 to 10 days. Conventional WWTPs are an intensive wastewater  12 
treatment technology. They are able to treat great amounts of water, occupying a relatively small surface area 
(Tchobanoglous and Burton, 1991). 
A compilation of results of various studies including influent and effluent concentration of PPCPs at conventional 
WWTPs based on activated sludge is displayed in Table 1.2. 
Table 1.2. Minimum, maximum and (average) concentrations of various pharmaceuticals and personal care products (in ng L-1) and 
percentage of detection in influent and effluents of various conventional wastewater treatment plants around the world. 
Compound WWTPs influent % detect. WWTP effluent % detect. Country Ref. 
Ibuprofen 1200-2679 (2021) n.a. <LOD-2400 (489) n.a. Austria 1 
 968-2986 (1681) 100 131-424 (263) 100 UK 2 
 2800-25400 (12500) n.a. 500-2600 (1500) n.a. Greece 3 
 Max: 16500 (8450) n.a. Max: 773 (384) n.a. Canada 4 
 170-83500 (14600) 97 2-24600 (1960) 93 n.a. 5 
 3730-353000 (69700) n.a. <LOD-26500 (4130) n.a. Spain 6 
 (1900) n.a. (250) n.a. USA 7 
Diclofenac 905-4114 (2572) n.a. 780-1680 (1366) n.a. Austria 1 
 57-1161 (260) 100 6-496 (179) 100 UK 2 
 <LOD-3900 (2000) n.a. <LOD-2600 (1300) n.a. Greece 3 
 Max:1010 (204) n.a. Max: 748 (194) n.a. Canada 4 
 105-4110 (1340) 81 35-1950 (680) 85 n.a. 5 
 <LOD 0 <LOD 0 Spain 6 
Acetaminophen 68107-482687 (211380) 100 1826-24525 (11733) 100 UK 2 
 108383-246641 (178116) 100 >80-1575 (353) 86 UK 2 
 4700-52500 (20600) n.a. 500-1700 (900) n.a. Greece 3 
 1571-37458 (23202) n.a. <LOQ n.a. Spain 8 
 (960) n.a. <LOD n.a. USA 7 
Tonalide 210-1106 (760) n.a. 144-170 (158) n.a. Austria 1 
 Max: 2000 (804) n.a. Max: 600 (274) n.a. Canada 4 
 210-1690 (990) 100 144-200 (162) 100 n.a. 5 
Oxybenzone n.a. n.a. 1-30 (11) 71 South Korea 9 
Triclosan 33-463 (228) 100 13-82 (57) 100 UK 2 
 <LOD-1000 (800) n.a. <LOD n.a. Greece 3 
 4010 (1930) n.a. Max: 324 (108) n.a. Canada 4 
 1520-4430 n.a. (810) n.a. USA 10 
 <LOQ-2417 (860) n.a. <LOQ-512 (219) n.a. Spain 8 
Ethynilestradiol 0.4-70 (4.2) 91 0.2-5 (0.9) 59 n.a. 5 
 <LOD 0 <LOD 0 Sweden 11 
 n.a. n.a. 1.3 14 South Korea 9 
1. Clara et al. (2005), 2. Kasprzyk-Hordern et al. (2009), 3. Kosma et al. (2010), 4. Lishman et al. (2006), 5. Miège et al. (2009), 6. Santos et al. (2009), 7. Yu 
et al. (2006), 8. Rosal et al. (2010), 9. Kim et al. (2007), 10. Katz et al. (2013), 11. Zorita et al. (2009); n.a.: not available. 
Non-steroidal antiinflammatory drugs (NSAIDs) take part of a therapeutical group widely used nowadays, and 
consequently acetaminophen and ibuprofen are the ones being found at higher concentration levels in raw wastewater. In 
the lower concentration level of PPCPs in the environment have been reported the detection of steroid hormones, 
generally at low ng L-1 and oftentimes below detection limits (Daughton and Ternes, 1999; Carballa et al., 2004).  13 
However, it should be noted that in spite of the low concentrations, estrogens could induce serious chronic effects, such 
as endocrine disruption (Ingerslev et al., 2003). The occurrence of antibiotics in WWTPs has also been reported in 
various studies (Yang and Carlson, 2004). 
Activated sludge WWTPs are not specifically designed to eliminate PPCPs and thus removal rates are very variable and 
compound-dependent. A recent report by the EPA includes a review of recent literature on wastewater treatment 
technologies and their ability to remove 16 emerging organic contaminants, including many PPCPs. Average removal 
efficiencies were calculated from a collection of as many as 41 full-scale WWTPs based on activated sludge, and 
removal rates for various PPCPs are displayed in Table 1.3. Note that the treatment systems used to obtain the presented 
data on the table did not include activated sludge systems that reported design modifications from the conventional 
activated sludge WWTPs (e.g. those that aim to remove nutrients). Although there are many variations of this process, 
further division of activated sludge categories was impractical (EPA, 2010). 
Table 1.3. Minimum, maximum and average removal efficiencies of various PPCPs at full-scale activated sludge WWTPs treating 
municipal wastewater (adapted from: EPA, 2010). 
Compound Removal efficiency (%) 
 Min Max Avg # of WWTPs used to calculate removal 
Ibuprofen 43 100 90 32 
Acetaminophen >90 100 97 4 
Diclofenac 7 >99 44 23 
Tonalide 13 97 67 20 
Oxybenzone >8 >96 76 6 
Triclosan >67 100 89 22 
Ethynilestradiol >1 >99 66 13 
Treatment performance was found to vary among the conventional WWTPs under study, majorly as a function of the 
characteristics of inflowing wastewater. Average removal efficiencies were very variable and compound-dependent. 
PPCPs may be removed from wastewater during activated sludge treatment by mechanisms of biodegradation and/or 
adsorption to the particulate matter. Some compounds undergo rapid biodegradation (e.g. acetaminophen) in 
conventional WWTPs (Yu et al., 2006; Miège et al., 2009; Kosma et al., 2010; Rosal et al., 2010). Likewise, ibuprofen 
and triclosan are consistently removed in most treatment plants (Clara et al., 2005; Lishman et al., 2006). However, some 
compounds exhibit variable removal, (e.g. diclofenac), while others, such as carbamazepine, have shown to be very 
recalcitrant (Kosma et al., 2010). In fact, in some occasions higher concentrations have been found in the effluent than in 
the influent, which is attributed to desorption and/or deconjugation processes (Kasprzyk-Hordern et al., 2009; Zorita et 
al., 2009). The more hydrophobic substances may attach to suspended solids or activated sludge. To this respect, 
Carballa et al. (2005) found how compounds with high sorption properties such as tonalide and diclofenac were 
significantly removed during coagulation-flocculation assays encompassing different doses and types of coagulants at 
different temperatures, whereas hydrophilic compounds (e.g. ibuprofen and carbamazepine) were not affected. 
Conversely, Jelić et al. (2011) found no accumulation of diclofenac in sludge samples from three conventional WWTPs. 
Treated effluent of WWTPs can either be disposed in surface waters or be reused for multiple applications. Additionally, 
the waste sludge, after its drying and treatment, could be applied to the land as fertilizers. In this way, remaining 
concentrations of PPCPs may transfer to soil and surface waters. 
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1.5. Removal of pharmaceuticals and personal care products through tertiary and advanced 
treatment technologies 
Since conventional activated-sludge WWTPs have shown to be unable to completely eliminate PPCPs, as well as other 
specific and priority substances included in the Water Framework Directive (EC, 2000a), a number of advanced (or 
tertiary) treatment technologies, which can provide further removal of these substances are being explored and 
developed lately in this sense. Already, a whole array of oftentimes fairly standardized unit processes is available so as 
to remove PPCPs by transformation or removal by physical and chemical methods, including adsorption or filtration. 
These include activated carbon (Ternes et al., 2002; Snyder et al., 2007), ozonation (Rosal et al., 2010), photo-Fenton 
(Rodríguez-Gil et al., 2010), UV radiation (Kim et al., 2009), ultrasonic irradiation (Naddeo et al., 2009), chemical 
AOPs (involving hydroxyl radicals), which generally use a combination of oxidization agents (e.g. H2O2, O3, TiO2, etc.), 
irradiation (UV or ultrasound) and catalysts (Klavarioti et al., 2009; Liu et al., 2009), chlorine dioxide oxidation (Huber 
et al., 2005), membrane technologies (Yoon et al., 2006; Snyder et al., 2007), and membrane bioreactors (Kimura et al., 
2005; Quintana et al., 2005; Shariati et al., 2010). As an example the anti-inflammatory drug diclofenac has consistently 
shown to be well photodegraded under UV treatment (Andreozzi et al., 2003; Zhang et al., 2008; Kim et al., 2009). This 
substance also gets well mineralized under ozonation (Rosal et al., 2010) and chlorine disinfection (Kosma et al., 2010). 
Average removal efficiencies of various PPCPs achieved under different tertiary treatment technologies are displayed in 
Table 1.4 (EPA, 2010). 
Table 1.4. Min, Max and average removal efficiencies of various pharmaceuticals and personal care products under different 
advanced treatment technologies for municipal wastewater treatment at full-scale (EPA, 2010). 
Compound Technology Min Max Avg (%) # systems used to calculate 
removal 
Ibuprofen Chlorine disinfection >43 100 78 5 
 Ozonation >90 100 95 2 
 Reverse Osmosis - - 72 1 
 UV disinfection >81 100 90 6 
Acetaminophen Chlorine disinfection >90 >99 95 2 
 Reverse Osmosis - - 90 1 
 UV disinfection - - 90 1 
Diclofenac Chlorine disinfection >18 >90 66 3 
 Reverse Osmosis - - 90 1 
 UV disinfection >86 >91 89 3 
Tonalide Chlorine disinfection 64 93 79 2 
 UV disinfection - - 52 1 
Oxybenzone Chlorine disinfection >8 >95 51 2 
 Reverse osmosis - - 95 1 
 UV disinfection >89 >96 92 3 
Triclosan Chlorine disinfection >67 >99 83 4 
 Ozonation 99 100 99 2 
 Reverse Osmosis - - 67 1 
 UV disinfection >71 >99 90 5 
Ethynilestradiol Chlorine disinfection 1 72 42 4 
Although conventional tertiary or advanced treatment technologies have shown to enhance the elimination of these 
contaminants, they are very unlikely to be implemented in the context of wastewater treatment of small communities, 
even if the technology is improved, due to energy and economic constrains. To this regard, decentralized, extensive low- 15 
cost treatment technologies, such as constructed wetlands, emerge as a great alternative for wastewater treatment and 
reuse, which require almost no maintenance and energy consumption. Their successful implementation at full-scale has 
shown their capacity to degrade all kind of contaminants, from conventional parameters to heavy metals or pathogens. 
Just in recent years their potential on the removal of PPCPs is being explored. The characteristics, advantages and 
disadvantages and performance of constructed wetlands in the treatment of municipal wastewater are shown in the 
following section. 
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2. Constructed wetlands: a decentralized wastewater treatment ecotechnology 
Constructed wetlands (CWs) are natural wastewater treatment systems that consist of a properly designed shallow basin, 
which contains a substrate that is planted with aquatic vegetation. Other components such as microorganisms and aquatic 
invertebrates develop naturally. These systems are constructed to mimic the microbiological, biological, physical and 
chemical processes that occur in a natural wetland but in a more controlled environment to treat wastewater (Kadlec and 
Wallace, 2009). 
These natural treatment systems constitute a cost-effective and technically feasible approach for the treatment of 
wastewater for several reasons: 
- Can be less expensive to build than other treatment options. 
- Low operational and maintenance (O&M) expenses (energy and supplies). Easy to maintain (do not require 
highly qualified staff). 
- Able to tolerate fluctuations in flow and load. 
- Promote biodiversity. As an example, restored wetlands are becoming common in agricultural landscapes of 
northern Europe so as to increase nutrient retention as well as increasing species diversity (Thiere et al., 2009; 
Matamoros et al., 2012a). 
- Can be easily integrated into the natural and rural landscape, and provide aesthetic, commercial and habitat value 
(Llorens et al., 2009). 
- Possible commercial revenue from flower harvesting and/or aquaculture (Jana, 1998). 
However, they have some limitations: 
- Generally high land area requirement: they may be more economical than other technologies, but only if land is 
available and affordable. While activated sludge technology requires approximately 0.06 m2/PE (Cooper, 2005), 
vertical subsurface, horizontal subsurface and free water surface CWs require 2, 5 and 8 m2/PE, respectively to 
attain the same contaminat removal efficiencies (Cooper, 2005; Vymazal, 2005; Kadlec, 2009). 
- Poor maintenance or design can lead to excessive clogging, which can affect hydraulics and treatment 
performance (Knowles et al., 2011). 
Since the implementation of the Water Framework Directive 2000/60/EC (EC, 2000a), as well as the Directive 
91/271/CEE concerning urban wastewater treatment (EC, 1991), there is a need to comply with stringent regulations in 
many countries around Europe, especially for the treatment of small communities. This has attracted the focus to 
decentralized wastewater treatment ecotechnologies, existing an increasing demand for economical, aesthetic and 
ecologically sustainable treatment systems. 
To this regard CWs, and other biological treatment technologies such as waste stabilization ponds, require very low to no 
energy consumption, and are easy to operate. Thus, they constitute a good alternative for wastewater treatment in small 
communities. Indeed, constructed wetlands have been extensively used at full-scale across the world since the 80s, for 
the treatment of not only municipal wastewater but all kinds of wastewater including stormwater, landfill leachate, 
tannery wastewater, and other industrial wastewaters (Schulz et al., 2001; Behrends et al., 2007; Nivala et al., 2007; 
Vymazal, 2009). They have been widely implemented in countries like France (Molle et al., 2005), UK (Weedon, 2003; 
Cooper, 2005), Denmark (Brix and Arias, 2005) or Czech Republic (Vymazal, 2002), and their implementation is 
increasing in countries like Spain (Vera et al., 2011) or Italy (Masi et al., 2007). Numerous studies have shown their 
capability to maintain hydraulic, technical, economic, environmental and ecological benefits (Vymazal, 2002; Dixon et 
al., 2003; Zhou et al., 2009). 
There are several types of constructed wetlands. They can mainly be divided into subsurface flow (horizontal or 
vertical), surface flow constructed wetlands, and hybrid systems, which are a combination of different types. 
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2.1. Horizontal subsurface flow constructed wetlands 
This type of wetlands consist of gravel beds planted with wetland vegetation, where the wastewater is intended to remain 
below the top of the substrate and to flow horizontally in and around the roots and rhizomes of the plants. These 
wetlands are always flooded and water depth usually remains between 0.3 and 0.9 m (between 0.05 and 0.1 m beneath 
the surface of the bed). The recommended organic loading rate (OLR) is around 6 g of biochemical oxygen demand 
(BOD5) m-2 d-1 (García and Corzo, 2008). The biofilm that grows on the granular media and the roots and rhizomes of 
the vegetation plays a major role in the removal of contaminants from wastwater. 
Horizontal subsurface flow (HF) constructed wetlands are typically composed by: inlet piping, an impervious liner, filter 
media, emergent vegetation and outlet piping. A diagram of a conventional HF wetland is depicted in Fig. 2.1. 
  
Figure 2.1. Horizontal subsurface flow constructed wetland schematic (adapted from Pedescoll, 2010). 
They are good for total suspended solids (TSS), BOD5 and bacteria removal and denitrification. However, they are poor 
at nitrification because of limited oxygen transfer capacity (OTC) (Cooper, 1999; Tyroller et al., 2010). Since the water 
is not exposed, the risk associated with exposure to pathogenic organisms is minimized and they do not provide suitable 
habitat for mosquitos (Kadlec and Wallace, 2009). 
2.2. Vertical subsurface flow constructed wetlands 
In this type of wetlands water is distributed across the surface of a sand or gravel bed planted with emergent vegetation, 
and the effluent is collected from the bottom of the media, where the water is freely draining. The treatment of the water 
occurs as it percolates through the filter media and the plant root zone.  
There exist several variations of vertical subsurface flow (VF) wetlands. In the most common design the bed is usually 
comprised of several layers of different grain size and contains a network of draining perforated pipes. They are usually 
fed intermittently and frequently loading and resting periods are applied. This is the case of many systems in France, 
where 2 or 3 beds work alternatively. In the French VF systems, the wastewater is fed without a previous primary 
treatment (Molle et al., 2008), causing the accumulation of a layer of solids on the top of the bed, which in turn acts as a 
filter. The alternation of cycles of feed and rest promote mineralization of the solid deposits during resting phases (Molle 
et al., 2005). In VF wetlands in general –usually comprised of a single bed-, it is the special operating conditions (i.e. 
intermittent dosing and unsaturated bed) that allow a higher organic loading rate to be applied in comparison to HF beds. 
Applied OLR values vary significantly from place to place and range from 20 g BOD5 m-2 d-1 in Denmark (Brix and 
Arias, 2005) up to 180 g BOD5 m-2 d-1 in French VF systems (just screened wastewater). The components of a typical 
VF wetland are shown in Fig. 2.2. 
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Figure 2.2. Basic elements of a vertical subsurface flow constructed wetland (adapted from Pedescoll, 2010). 
The configuration of these systems confers very different properties to those of HF wetlands. They have a much greater 
OTC than HF beds, which makes them good for nitrification. Oxygen transfer is achieved by means of diluted oxygen 
present in wastewater, convection while intermittent loading, and diffusion processes occurring between doses (Torrens 
et al., 2009). The high OTC also leads to good removal of BOD5 and chemical oxygen demand (COD); they are also able 
to remove some bacteria (Headley et al., 2013) and are also considerably smaller (about 2-3 m2/PE) than HF systems 
(about 5 m2/PE) (Cooper, 2005; Vymazal, 2005). Nevertheless, they are less good for suspended solids removal and, 
more specially for single VF systems were no resting periods are allowed, clogging of the media may occur rapidly if the 
granular material selection and the hydraulic loading rates are not correct (Cooper, 1999; Platzer and Mauch, 1997; 
Kayser and Kunst, 2005). 
2.3. Free water surface wetlands 
In this type of wetlands, the wastewater flows above the top of the media (with some kind of impervious layer 
underneath), which can be of many types (e.g. clay, soil, gravel, etc.), since the wastewater is not intended to be filtered 
through it. These wetlands contain areas of open water, floating vegetation, and emerging plants, either by design or as 
an unavoidable consequence of the design configuration. A schematic of a conventional FWS wetland is depicted in Fig. 
2.3. 
 
Figure 2.3. Free water surface constructed wetland schematic (adapted from Pedescoll, 2010). 
Because the water is exposed during the treatment process, it is common that these types of wetlands attract a variety of 
wildlife (i.e. insects, mollusks, fish, amphibians, reptiles, birds and mammals) (Kadlec and Knight, 1996). Moreover,  19 
since they represent a risk for public health due to human exposure to pathogens, they are commonly applied for tertiary 
treatment of secondary or tertiary treatment effluents (e.g. activated sludge systems, waste stabilization ponds, SSF 
wetlands, etc.). They are especially appropriate for restoration of deteriorated areas or attenuation of agricultural runoff 
at tertiary treatment level (Thiere et al., 2009; Matamoros et al., 2012a; Matamoros and Salvadó, 2012). 
2.4. Hybrid systems 
Various types of constructed wetlands may be combined in order to achieve higher treatment efficiency, especially for 
nitrogen and pathogens. These hybrid systems are normally comprised of VF and HF systems arranged in different 
possible manners. While in HF wetlands nitrification is not achieved due to a lack of oxygen, VF wetlands can provide 
good conditions for nitrification but no denitrification occurs in these systems. Thenceforward, the strengths and 
weaknesses of each type of system balance each other out and in consequence it is possible to obtain an effluent low in 
BOD and in total nitrogen (TN) concentrations (Vymazal, 2005). Different combinations are possible, including HF 
followed by VF wetlands, VF followed by HF wetlands and other stages of filters including water recirculation from one 
stage to another (Brix and Arias, 2005). 
 
3. Removal and behavior of pharmaceuticals and personal care products in 
constructed wetlands for urban wastewater treatment 
The elimination of pharmaceuticals and personal care products (PPCPs) in constructed wetlands (CWs) takes place as a 
result of the simultaneous occurrence of various removal mechanisms, including biodegradation, adsorption, 
photodegradation, plant uptake, or hydrolysis. Some removal mechanisms will predominate in some wetland 
configurations in respect to others (e.g. photodegradation will only take place in free water surface (FWS) wetlands). 
Average removal efficiencies of target PPCPs at several pilot and full-scale CW systems of different configurations are 
shown in Table 3.1. 
Table 3.1. Average removal efficiencies (R.E.) of various pharmaceuticals and personal care products at different pilot and full-scale 
constructed wetland systems of various configurations. 
Compound Range Avg R.E. 
(%) 
Type of treatment Ref. 
Ibuprofen 95-96 96 Restoration FWS wetland (receives secondary effluent from a WWTP) 1 
 48 (shallow)-
81 (deep) 
n.a. Pilot-scale HF wetlands (different depths) with injection of contaminants 2 
 n.a. 99 Experimental pilot -scale VF wetland (5 m2) 3 
 n.a. <15 Restored wetland system fed with natural waters impacted by urban and 
agricultural run-off 
4 
 n.a. >95 Pilot-scale VF wetland (5 m2) 5 
Diclofenac n.a. 73 Experimental pilot -scale VF wetland (5m2) 3 
 n.a. <15 Restored wetland system fed with natural waters impacted by urban and 
agricultural run-off 
4 
 n.a. 65 Pilot-scale VF wetland (5 m2) 5 
 65-87 77 Three hybrid treatment Systems (ponds and CWs) 6 
 73-96 n.a. FWS wetland (receives secondary effluent from WWTP) 7 
 n.a. 21 Household HF wetland 8 
Acetaminophen >90 >90 Pilot—scale VF wetland (5 m2) 5 
Tonalide 88-90 89 Restoration FWS wetland (receives secondary effluent from a WWTP) 1  20 
 n.a. 82 Experimental pilot-scale VF wetland (5 m2) 3 
 n.a. 15-40 Restored wetland system fed with natural waters impacted by urban and 
agricultural run-off 
4 
 n.a. 70 Pilot-scale VF wetland (5 m2) 5 
Oxybenzone n.a. >95 Pilot-scale VF wetland (5 m2) 5 
 n.a. 98 Household HF wetland 8 
 n.a. 77 Tertiary treatment by Pond + FWS wetland 9 
Triclosan n.a. >40 Restored wetland system fed with natural waters impacted by urban and 
agricultural run-off 
4 
 n.a. >80 Pilot-scale VF wetland (5 m2) 5 
 n.a. 86 Tertiary treatment by Pond + FWS wetland 9 
1. Llorens et al. (2009); 2. Matamoros et al. (2005); 3. Matamoros et al. (2007); 4. Matamoros et al. (2012a); 5. Ávila et al, 2014c; 6. Hijosa-Valsero et al. 
(2010a); 7. Matamoros et al. (2008b); 8. Matamoros et al. (2009a); 9. Matamoros and Salvadó (2012). 
The anti-inflammatory drug ibuprofen (IB) has shown to be readily removed in the three types of CWs (HF, VF and 
FWS). Results by Matamoros et al. (2005) and Matamoros and Bayona (2006) show high removal efficiencies in HF 
wetlands (60 - 80%), observing that the elimination rates are higher in shallower (0.27 m) than deeper beds (0.5 m). 
Matamoros et al. (2008a) found a prevalence of OH-IB over Ca-IB metabolite in a HF wetland, which would be 
explained by its predominant aerobic biodegradation. A comparison between different seasons by Hijosa-Valsero et al. 
(2011b) in HF beds shows a seasonal variability, with lower removal efficiencies in winter (<40%) than in summer 
(>90%). Moreover, two injection experiments carried out at that same experimental plant in Barcelona, Spain, showed 
how its removal highly depended on the existence of a high redox status, which would promote aerobic biodegradation 
of this drug (Ávila et al., 2010, 2013a). The removal of IB is also high in FWS wetlands, as documented by Llorens et al. 
(2009) and Matamoros et al. (2008b), where efficiencies of over 90% are detected. High elimination rates were also 
reported for VF beds, with efficiencies of around 99% for unsaturated vertical wetlands (Matamoros et al., 2007). 
Conversely, although diclofenac (DCF) has been reported to be recalcitrant in activated sludge wastewater treatment 
plants (WWTPs) (Heberer, 2002), this substance shows a variable removal in CWs, ranging from values as low as 21% 
in HF beds (Matamoros et al., 2009a; Matamoros and Bayona, 2006) up to values of 99% at experimental scale HF 
wetland under an injection experiment (Ávila et al., 2010) or a value of 73% in a VF wetland in Denmark (Matamoros et 
al., 2007). In FWS wetlands average removal efficiencies have been reported to be as high as 96% and 73-96% in studies 
carried out by Llorens et al. (2009) and Matamoros et al. (2008b), respectively. This could be attributed to its large 
removal through photodegradation, as reported by Andreozzi et al. (2003). This substance is fairly hydrophilic and was 
not detected in the particulate matter associated to the gravel matrix of CWs, as reported by Matamoros and Bayona 
(2006). A high variability on the elimination of diclofenac was also observed by Hijosa-Valsero et al. (2011b) in various 
experimental meso-scale HF wetlands, who showed that its degradation was favored by high temperatures (summer VS 
winter) and found variable removal efficiencies in Barcelona (around 70%) and in León (<12%) wetlands. Although 
reductive dehalogenation has been claimed as a possible important removal mechanism for this compound (Ávila et al., 
2010), other studies show how its removal seems to be enhanced by more oxidizing conditions (Ávila et al. 2013a). 
In regards to the removal of the estrogen ethynilestradiol in CWs, Gray and Sedlak (2005) found a 41% removal after 
spiking it in concentrations slightly above background concentrations in a full-scale FWS wetland (750 m2) with a depth 
of 0.5 m and a hydraulic retention time of 84 h, and reported sorption as a major mechanism for its removal in the 
aqueous phase. Song et al. (2009) evaluated the influence of saturated vs. unsaturated conditions in VF units in regards 
to the removal of estrogens, and found out that unsaturated conditions (and thus more oxidized conditions) were better 
for the removal of this type of pollutants. 
What is more, the fate of the musk fragrance tonalide in constructed wetlands has been previously investigated by 
several authors, such as Matamoros et al. (2008b) who reported elimination rates of 88 - 90% in a full-scale FWS 
wetland, which did not show a dependence on the season, presumably due to their low biodegradability properties (i.e. 
major removal mechanism through interaction with organic matter and sediment). In fact, in another study, this time in 
two pilot HF wetlands at Les Franqueses del Vallès (Barcelona), Matamoros and Bayona (2006) found this fragrance 
together with galaxolide to be the most abundant on the gravel bed and the suspended particulate matter, attributing the  21 
removal of these musks to hydrophobic interactions with the organic matter and the biofilm. Moreover, no water depth 
effect dependence was found for this compound. On the contrary, Hijosa-Valsero et al. (2011b) reported a possible 
dependence of this compound on temperature, since the removal efficiencies were significantly higher in summer than in 
wintertime, presumably due to the release of hydrophobic compounds in winter (i.e. galaxolide and tonalide), under a 
lower biofilm and plant activity. Removal efficiencies in VF wetlands were also reported by Matamoros et al. (2007) to 
be moderately removed with elimination rates ranging from 75 – 82%. 
The behavior of the sunscreen agent oxybenzone in CWs has been reported by Matamoros et al. (2007) in a VF wetland, 
where it was very efficiently removed (>95%), and by Matamoros et al. (2009a), where the removal was also >95% in 
HF wetlands and 90% in VF wetlands. The authors suggest that it could be partially removed by sorption onto the 
particulate matter, although it is majorly removed by biodegradation (Ávila et al., 2013a, 2014b). 
In regards to the elimination of triclosan, Park et al. (2009) reported removal efficiencies in FWS wetlands in South 
Korea of above 60%. Matamoros et al. (2012a) found triclosan to be the substance achieving the highest removal 
efficiency (>40%) among all studied compounds in a restored wetland in Denmark. 
3.1. Design and operational factors affecting the removal of pharmaceuticals and personal care 
products in constructed wetlands 
The removal of contaminants in CWs occurs as a result of complex physico-chemical and microbial interactions. The 
rates of these processes depend on a variety of design and operational factors such as depth of the bed, type and size of 
media, hydraulic and organic loading rates, feeding strategy and artificial/external aeration, among others. The design of 
CWs is often carried out using the black box concept, and reduced treatment efficiency may occur when wetlands are 
constructed without considering the influence of these parameters. Most of the available research concerning design and 
operational parameters’ influence on treatment performance focuses on conventional water quality parameters. Only in 
the last decade, the effect of these parameters on the removal of pharmaceuticals and personal care products (PPCPs) has 
been investigated. Those include very few studies evaluating the influence of water depth (Matamoros et al., 2005; 
Matamoros and Bayona, 2006); primary treatment (Ávila et al., 2013a), operation under cycles of saturation/unsaturation 
(Ávila et al., 2013a); type of organic matter (Matamoros et al., 2008a); type of granular media (Dordio et al., 2009, 
2010) and other different design parameters and modes of operation (Hijosa-Valsero et al., 2010b, 2011b; Zhang et al., 
2012a,b; Ávila et al., 2014b). Therefore the optimization of the performance of CWs in terms of PPCP removal stands as 
a necessity that can be achieved through the identification of the optimal design and operational factors of these 
treatment systems. 
3.1.1. Behavior of PPCPs in horizontal subsurface flow constructed wetlands 
HF wetlands display seasonal effects for PPCP removal, with lower removal efficiencies during the cold season at lower 
water temperatures. Seasonal patterns have been observed at various CW systems at mesoscale in Barcelona, NE Spain 
(Hijosa et al., 2011b; Ávila et al., 2013a) and in León, NW Spain (Hijosa et al., 2010b; Reyes-Contreras et al., 2012), 
being removal efficiencies consistently better in summer than in winter for almost all of the studied PPCPs. 
It is generally known that microbial activity is highly influenced by temperature. Microorganisms in wetlands usually 
reach their optimal activity at warm temperatures (15-25ºC), especially nitrifying and proteolytic bacteria (Truu et al., 
2009). The same trend has been found to occur for denitrifying bacteria (Spieles and Mitsch, 2000; Boulêtreau et al., 
2012). The elimination of PPCPs has been found to depend on water temperature, being especially important for 
biodegradable compounds (e.g. ibuprofen, diclofenac). Moreover, the presence of vegetation during the summer season, 
could also contribute to the removal of PPCPs, either by plant assimilation, and to a higher extent by the transfer of 
oxygen to the rhizosphere (Brix, 1993; Tyroller et al., 2010). This should allow the creation of microenvironments with 
different redox conditions, which in turn would promote the development of microbial biofilms with functionally 
different respiration processes (Wiessner et al., 2005; Kadlec and Wallace, 2009; Ávila et al., 2013a). 
What is more, it is also widely known that removal of most pollutants, including PPCPs, in CWs occur primarily due to 
microbial activity (García et al., 2010). In fact, the removal efficiency of PPCPs in CWs is oftentimes higher than that  22 
achieved in conventional wastewater treatment plants (WWTPs), which could presumably be due to their higher 
microbial diversity occurring in wetland ecosystems (Kadlec and Wallace, 2009). CWs can be designed to favor a wide 
range of redox conditions, therefore enhancing a variety of biological processes and removal of multiple contaminants in 
the same CW bed. In turn, CW technology can be optimized if the factors influencing their performance are identified. 
For instance, operating HF wetlands in batch (or cycles of fill and drain) seems to be a very important factor promoting 
the elimination of most contaminants. The alternation of phases of saturation and unsaturation promotes the existence of 
a higher redox status as compared to functioning under saturated conditions, which in turn enhance significantly the 
elimination of PPCPs (Zhang et al., 2012b; Ávila et al., 2013a). Substances whose major removal mechanism is thought 
to be biodegradation under aerobic conditions (e.g. ibuprofen) are those that show the largest differences (Ávila et al., 
2013a). In general, the operation under cycles of saturation and unsaturation seems to be a good strategy to enhance the 
treatment performance of HF CWs by promoting the fluctuation of redox conditions where robust aerobic facultative 
biofilms can operate (Stein et al., 2003; Faulwetter et al., 2009). 
Other design factors for HF wetlands are water depth, applied hydraulic loading rate, grain size and type of media. In 
particular, water depth seems to be a determining factor in this type of wetlands, which affects the redox conditions, 
oxygen supply and thus the treatment performance of the wetlands. Shallower wetlands appear to have higher redox 
potential and thus promote more variate and energetically favorable reactions, which in turn enhance the degradation of 
PPCPs (Matamoros et al., 2005). Other authors have shown experimental evidence, which support this hypothesis 
(García et al., 2003a, 2005; Headley and Davison, 2005; Huang et al., 2005; Matamoros and Bayona, 2006). 
In regards to the granular media of HF beds, in general a wide range of materials and sizes have been applied around the 
world, and its selection is in many cases dictated by the availability, price and local practices of a certain region. Some 
studies indicate the importance of using hard, durable and homogeneous materials that do not contain fine grains, which 
might clog the media (García and Corzo, 2008; Pedescoll et al., 2009). In general, finer materials (D60 = 3.5 vs. 10 mm) 
have been recommended in HF beds when low organic loads are applied since they provide a greater surface area for 
microbial biofilms. Finer gravel promotes a higher growth of the vegetation and in conjunction a higher removal of 
pollutants such as ammonia (García et al., 2005). However, it is important to have in mind that the finer the material, the 
greater the risk of clogging and hydraulic problems. Moreover, although usually granite gravel is used in HF wetlands, 
other alternative sorbents have emerged so as to increase the adsorption capacity of these wetlands, such as light 
expanded clay aggregates (Dordio et al., 2009, 2010). This is expected to be especially important for hydrophobic 
compounds such as fragrances. The influence of granular size in HF wetlands’ PPCPs removal has not to date been 
assessed, though it should majorly show effects on hydrophobic substances that get attached to particulate matter. 
Finally, it is well known that in HF wetlands the oxygen demand exerted by the degradation of pollutants in wastewater 
exceeds the amount of oxygen available within the wetland bed. In general, subsurface oxygen limitation is one of the 
main rate-limiting factors for traditional HF wetlands (Brix and Schierup, 1990; Kadlec and Wallace, 2009; Tyroller et 
al., 2010). For that reason, other variants such as the use of active aeration are being developed and implemented 
worldwide and have shown to enhance the treatment performance of this type of CWs (Wallace, 2001; Nivala et al. 
2013). However, this practice come at a heavy operational and maintenance cost, which is only justified if the 
improvement in the performance of the wetland offsets the cost of operation equipment and energy needs (Kadlec and 
Wallace, 2009; Nivala et al., 2012). To the best of our knowledge there are still no studies, which assess the removal of 
PPCPs within actively aerated HF wetlands. 
In conclusion, seasonal variations in environmental conditions are relevant factors to take into consideration for HF CW 
design, and operation and maintenance (O&M), especially at places showing high seasonality. In general, it has been 
observed that the treatment performance of HF CWs on PPCP removal is enhanced by the adoption of strategies that 
promote a higher redox status of the system. Operating HF wetlands in cycles of saturation and unsaturation stands as a 
very relevant strategy, which greatly enhances PPCP removal by promoting a higher redox status of the wetland bed. 
Water depth is also a critical factor influencing performance, being shallower wetlands of about 0.25-0.30 cm more 
efficient in PPCP removal than deeper HF CWs. 
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3.1.2. Behavior of PPCPs in vertical subsurface flow constructed wetlands 
In general, it has been observed that vertical subsurface flow (VF) wetlands are more efficient on the removal of PPCPs 
than horizontal subsurface flow (HF) wetlands, which agrees with other laboratory and experimental studies which 
suggest that aerobic pathways are in general more efficient in the degradation of these substances than anaerobic ones 
(Zwiener and Frimmel, 2003; Matamoros et al., 2007; Conkle et al., 2012; Ávila et al., 2013a). However, the relative 
importance of a particular degradation process in VF CWs can vary as a function of environmental factors, organic 
contaminant being treated, wetland configuration, and specific design and operational parameters. For instance, in 
unsaturated intermittently-loaded VF wetlands (typical), diffusion and convection processes depend on the loading 
strategy, being affected by the number of pulses, the volume of the pulse, and the duration of surface filter dewatering 
(Molle et al., 2006; Torrens et al., 2009). The choice of the filter media (i.e. grain size, grain material, depth of layers) is 
also crucial, and should simultaneously satisfy treatment needs, while avoiding clogging of the bed and maintaining 
oxygen renewal in the media (Cooper, 2003; Kayser and Kunst, 2005).  
In regards to the loading frequency, a higher volume of batch dosed at lower feeding frequencies should favor oxygen 
transfer into the media due to diffusion and mass convection. However, if the volume is too high, it could lead to 
decreased removal efficiency due to reduced contact time between the water and the biomass. On the other hand, if the 
loading is done too frequent, the capacity of oxygen renewal occurring between pulses could be limited, thus affecting 
removal processes such as nitrification. To this respect, differences could be more notable in the long-term (Molle et al., 
2006; Torrens et al., 2009). Further studies in this direction are needed. 
In general, the loading frequency is an important operational parameter to guarantee the good treatment performance of 
this type of treatment systems, where sufficient oxygen renewal and mineralization of the organic matter should be 
allowed. Applied hydraulic loading rates (HLRs) and potential accumulation of solid deposits on the bed surface should 
be carefully supervised and controlled, especially in non-rested VF wetlands, so as to avoid filter clogging and surface 
ponding, which could eventually decrease the efficiency and lifetime of the treatment system (Platzer and Mauch, 1997; 
Langergraber et al., 2003). 
Moreover, grain size is again an important factor to take into account. A recent study has evaluated the influence of this 
factor on PPCP removal and has shown a greater performance of sand-based (1-3 mm) than gravel-based (4-8 mm) VF 
wetlands (Ávila et al., 2014c). Results suggest that in gravel-based VF wetlands, lower contact together with lower 
solids retention capacity due to higher pores between grains would result in reduced treatment efficiency. In fact, it has 
been observed that a rapid flow downwards does not favor ammonia sorption onto the gravel bed, which might 
eventually decrease nitrification activity (Molle et al., 2006; Torrens et al., 2009). The lower surface area per unit 
volume in gravel-based as compared to sand-based VF beds, provided by a larger grain size, reduces oxygen diffusion 
and entrapment of solids, and may provide insufficient contact time between the biofilm and pollutants. On the other 
hand, in sand-based VFs, the higher surface area for biofilm attachment and higher oxygen availability may promote the 
existence or larger biomass and more diverse microbial communities. In fact, higher microbial biomass and activities 
have been found to take place in the upper part (about first 10 cm of a 50 cm VF) of a VF wetland, where a higher redox 
status prevails (Tietz et al., 2007).  
Although higher elimination rates have been found at sand-based systems (Ávila et al., 2014c), their long-term operation 
may make them more vulnerable to clogging. In practice, grain size as well as loading frequency should be carefully 
selected, as well as HLRs controlled (Matamoros et al., 2007), in order to ensure desired removal of PPCPs, as well as 
enough oxygen renewal and mineralization of organic matter so that no clogging develops in the filter beds. 
Nevertheless, in French-style VF wetlands, where various beds alternate cycles of feed and rest, it has been observed that 
very high hydraulic overloads can be applied without observing a decreased in the infiltration capacity or treatment 
performance of the system (aprox. 0.4-1.8 m d-1). Nevertheless, in particular case scenarios the grain and type of media 
used should be adapted to available local materials, and the use of gravel could constitute an acceptable solution. 
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3.2. Behavior of pharmaceuticals and personal care products in hybrid constructed wetland 
systems 
With the purpose of evaluating the treatment capacity and possible performance enhancement when various CW of 
different types are combined, a hybrid constructed wetland system consisting of three stages of VF, HF and FWS 
wetland (in this study followed by an open-air water tank indicated for water reuse) was designed, constructed and 
monitored at experimental and full-scale for the removal of conventional water quality parameters and PPCPs (Ávila et 
al., 2013b, 2014a,b). 
Results obtained in a full-scale hybrid system of the cited characteristics (surface areas of 317 m2, 219 m2 and 240 m2 for 
the VF, HF and FWS wetlands, respectively) showed to perform remarkably well in the removal of PPCPs, achieving 
very high overall removal efficiencies for the majority of the studied compounds (above 80% removal for all 
compounds) (Ávila et al., 2014a). The accumulated removal efficiencies in each treatment unit are displayed in Fig. 3.1. 
 
Figure 3.1. Accummulated removal efficiencies of various pharmaceuticals and personal care products at the different units of the 
pilot hybrid treatment system (Ávila et al., 2014a). Note: ibuprofen –IB-; diclofenac –DCF-; acetaminophen –ACE-; tonalide –
AHTN-; triclosan –TCS-; the industrial chemical compound bisphenol A –BPA-. 
Final effluent concentrations of target PPCPs were very low, being below the limit of detection for acetaminophen. The 
rest were in the ng L-1 order (20-100), which is in the range of those found in the environment, such as those reported by 
Matamoros et al. (2009b) in small ponds or lagoons. These concentrations are also in the range of those obtained in 
advanced treatment technologies applied at full-scale, such as ozonation or membrane filtration (Snyder et al., 2007; 
Rosal et al., 2010). 
The high removal efficiencies can be explained by differing existing physico-chemical conditions at different CW 
configurations, which would allow for the combination and synergy of various physicochemical and biological removal 
mechanisms to occur (e.g. biodegradation, sorption, volatilization, hydrolysis, and photodegradation) and thus achieve 
improved treatment efficiency of most pollutants (Faulwetter et al., 2009; Imfeld et al., 2009). In this sense, while 
aerobic metabolic pathways and solids retention are enhanced in VF wetlands, other removal mechanisms such as 
anaerobic biodegradation and sorption would predominate in HF beds. At last, the FWS wetland would be responsible 
for potential photodegradation of compounds, and less importantly through adsorption onto organic matter and uptake of 
plant material (Matamoros and Salvadó, 2012). 
The superior treatment performance of the VF over the other treatment units could be owed to energetically favorable 
aerobic microbial reactions, as well as hydrolysis reactions, taking place within this wetland type and provided by its 
design and operation strategy, which results in high effluent redox potentials and dissolved oxygen concentrations. 
However, the synergic nitrification-denitrification activity observed in the VF bed within the cited (Ávila et al., 2014a)  25 
and a previous study at the same treatment plant (Ávila et al., 2013b) suggest the co-existence of both aerobic and 
anaerobic microenvironments within this wetland bed, which would allow the occurrence of both processes to take place. 
This could be partially explained by the occurrence of a saturated layer at the bottom of the wetland bed, below draining 
pipes. Similarly, this finding indicates that although aerobic biodegradation and sorption onto organic matter may be the 
major removal mechanisms contributing to PPCP reduction in VF wetlands, alternative processes based on anaerobic 
metabolism could simultaneously be occurring at anoxic microsites or micropores within the wetland bed (i.e. in lower 
layers) (Cooper et al., 1996; Ávila et al., 2010), which contribute to its elimination. 
While substances like the musk fragrance tonalide show a great reduction within the HF presumably due to sorption 
processes, results for triclosan would exhibit little sorption capacity. The behavior of triclosan within the three different 
wetland configurations indicate aerobic biodegradation as the major removal mechanism involved in the elimination of 
this compound (Singer et al., 2002; Ying et al., 2007). Although triclosan has been detected in plant and sediments of a 
HF CW and its concentration generally decreased from inflow to outflow (Zárate et al., 2012), sorption and plant uptake 
does not appear to constitute a principal mechanism of triclosan removal in constructed wetlands. The similarly high 
removal efficiencies achieved for diclofenac in the current study in the HF bed if compared to the VF wetland suggest 
that various alternative mechanisms may determine the elimination of this compound, and to that respect, anaerobic 
biodegradation through reductive dehalogenation could constitute a predominant degradation pathway of diclofenac 
when anaerobic conditions prevail (Park et al., 2009; Ávila et al., 2010; Hijosa-Valsero et al., 2010a).  
The FWS wetland performed especially well for diclofenac. These results support photodegradation as a principal 
removal mechanism involved in diclofenac attenuation in water bodies (Buser et al., 1998; Andreozzi et al., 2003; 
Matamoros and Salvadó, 2012, 2013), together with less predominant mechanisms (i.e. aerobic/anaerobic 
biodegradation, plant uptake). Although the removal of triclosan was negligible, some more reduction within the water 
reuse tank seemed to occur, indicating that photooxidation processes may constitute a small contribution to its removal 
(Mezcua et al., 2004; Ávila et al., 2014b; Matamoros and Salvadó, 2012, 2013). Although the reduction of tonalide 
concentrations in the FWS could be attributed to sorption onto particulate matter and sediment, further reduction was 
achieved at the water reuse tank, suggesting photodegradation through sunlight exposure as one of the principal 
mechanisms of the fragrance tonalide removal within this type of wetland configuration. Similarly high removal 
efficiencies were obtained at other FWS wetlands operating as a tertiary treatment step (Matamoros et al., 2008b; 
Llorens et al., 2009; Matamoros and Salvadó, 2012). 
In conclusion, hybrid CW systems consisting of a combination of CW configurations, including a VF CW, a HF 
wetland, and a FWS wetland operating in series, has shown to be a very robust ecotechnology for wastewater treatment 
and reuse in small communities (Ávila et al., 2014a,b). The combination of different wetland configurations has shown 
to optimize a number of important treatment processes, achieving an excellent overall removal efficiency of PPCPs 
(above 80% for all studied substances), conventional water quality parameters (>90%), as well as a high disinfection 
capacity (Ávila et al., 2013b). This has been possible thanks to the occurrence of complementary abiotic/biotic removal 
pathways taking place under differing physico-chemical conditions existing at wetlands of different configuration. 
Concluding remarks 
This chapter shows how pharmaceuticals and personal care products (PPCPs) are a subgroup within the so-called 
‘emerging organic contaminants’ with comprise an extraordinarily diverse array of chemicals used in veterinary 
medicine, agricultural practice, human health and cosmetic care. PPCPs include prescription and non-prescription 
medications, nutritional supplements, diagnostic agents, as well as other consumer products such as disinfectants, 
fragrances, sunscreen agents and cosmetics. Even though most of them are polar, have a short half-lifetime in water, and 
are found in trace concentrations, they are considered pseudo-persistent pollutants. This is because of their universal, 
frequent usage by multitude of individuals and animals, which causes a continuos discharge into the environment 
oftentimes sourcing from either non-treated or insufficient wastewater treatment. Little is known about the degradation 
pathways and products of most PPCPs in the environment, and less is known about their intermediates of degradation, 
which just started to be explored. Conventional activated sludge wastewater treatment plants often provide insufficient 
removal of these substances, and in this context constructed wetlands constitute a good option for the removal of 
pharmaceuticals and care products from wastewater.  
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Constructed wetlands emphasize the transformation processes taking place in natural wetlands to treat wastewater. 
Wetlands are complex ecosystems and comprise a wide range of microenvironments that aim at pollutant removal. 
Biodegradation, sorption and photodegradation seem to be the major mechanisms involved in PPCP removal in 
constructed wetlands. While aerobic biodegradation and sorption predominate in vertical flow wetlands, horizontal 
subsurface flow wetlands should be especially important at anoxic biodegradation and sorption of contaminants. In 
surface flow wetlands photodegradation plays a major role in PPCP removal. Other mechanisms such as hydrolysis, 
plant uptake, sedimentation, contaminant accumulation, metabolic transformation, or phytovolatilization also contribute 
at a lower rate to PPCP removal. 
Constructed wetlands can be optimized so as to improve treatment performance. Design and operational factors such as 
water depth, hydraulic loading rate, grain size, or use of active aeration can have a major impact on the removal 
efficiency of PPCP removal. In general, vertical subsurface flow wetlands have shown to be more efficient on the 
removal of PPCPs than horizontal subsurface flow wetlands due to the aerobic environment promoted in the 
intermittently-fed, unsaturated typical vertical flow beds. 
The use of hybrid constructed wetland systems, which combine different wetland types, has shown to enhance the 
removal of PPCPs by combining different treatment processes occurring at various (physico-chemical and 
microbiological) microsites of the different wetland units. A combination of vertical flow, horizontal flow and free water 
surface wetlands in series has proven to achieve very high removal rates (above 80%) for most studied PPCPs, and 
constitutes a good alternative for the treatment of domestic wastewater in small or rural communities.  
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